Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Rupp H, Jäger B, Verboom C-N
Saving Lives Post-MI: Highly Purified Omega-3 PUFAs for the Prevention of Sudden Death
Journal of Clinical and Basic Cardiology 2002; 5 (3): 209-214

PDF    Summary    Overview   

Fig. 2: GISSI-P - Endpunkte This Image - Fig. 3: GISSI-P - Risikoreduktion Fig. 4: GISSI-P-Studie - Plötzlicher Herztod Fig. 5: Omega-3-Fettsäuren - Arrhythmien
Figure/Graphic 3: GISSI-P - Risikoreduktion
Use of highly purified omega-3 PUFAs in GISSI-Prevenzione was associated with significant reductions in the risk of a primary endpoint event (light bars) and reductions in the risk of several forms of cause-specific mortality (dark bars). Vitamin E alone had no significant effect on either primary outcome and the combination of highly purified omega-3 PUFAs plus vitamin E was not different from highly purified omega-3 PUFAs alone. Risk reductions derived from 4-way analysis; data from [9]
 
GISSI-P - Risikoreduktion
Previous Image Next Image   


Figure/Graphic 3: GISSI-P - Risikoreduktion
Use of highly purified omega-3 PUFAs in GISSI-Prevenzione was associated with significant reductions in the risk of a primary endpoint event (light bars) and reductions in the risk of several forms of cause-specific mortality (dark bars). Vitamin E alone had no significant effect on either primary outcome and the combination of highly purified omega-3 PUFAs plus vitamin E was not different from highly purified omega-3 PUFAs alone. Risk reductions derived from 4-way analysis; data from [9]
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung